Mauriac Syndrome: Case Report and Review of the Literature

Simple item page
dc.authoridTopaloğlu, Ömercan/0000-0003-3703-416X
dc.authoridDemiral Sezer, Sibel/0000-0002-7577-5084
dc.authoridDemir, Bilgin/0000-0003-4380-9419
dc.authorwosidTopaloğlu, Ömercan/O-5534-2018
dc.authorwosidDemiral Sezer, Sibel/GSN-7413-2022
dc.authorwosidDemir, Bilgin/GRX-2032-2022
dc.contributor.authorTopaloglu, Omercan
dc.contributor.authorSezer, Sibel Demiral
dc.contributor.authorDemir, Bilgin
dc.contributor.authorAkarken, Derya
dc.date.accessioned2024-08-04T20:09:53Z
dc.date.available2024-08-04T20:09:53Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThis is a case report of a young male with poorly controlled type 1 diabetes mellitus who presented with the clinical features of diabetic ketoacidosis. Once the patient was stabilized, he was examined for hepatomegaly and elevated liver enzymes. Along with the other clinical features, the patient was diagnosed as a case of Mauriac Syndrome. Mauriac Syndrome, initially described by Mauriac in 1930, is one of the causes of hepatomegaly and elevated liver enzymes in poorly controlled diabetic patients. However, hepatomegaly, growth retardation and other clinical features of the syndrome have been found to be reversible with optimization of insulin therapy. In patients with poorly controlled diabetes, Type 1 diabetic patients must be closely observed for sexual maturation and growth. After optimal therapy has been given, close follow-up is essential to observe the regression of clinical features.en_US
dc.identifier.doi10.25179/tjem.2017-56496
dc.identifier.endpage135en_US
dc.identifier.issn1301-2193
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85039857512en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage131en_US
dc.identifier.trdizinid282363en_US
dc.identifier.urihttps://doi.org/10.25179/tjem.2017-56496
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/282363
dc.identifier.urihttps://hdl.handle.net/11616/92488
dc.identifier.volume21en_US
dc.identifier.wosWOS:000423949600008en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal of Endocrinology and Metabolismen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMauriac syndromeen_US
dc.subjecthepatic glycogenosisen_US
dc.subjecttype 1 diabetes mellitusen_US
dc.titleMauriac Syndrome: Case Report and Review of the Literatureen_US
dc.typeReview Articleen_US

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.

Customize